"Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development". Cellular and Molecular Life Sciences. 59 (2): 288–306. February 2002. doi:10.1007/s00018-002-8423-9. PMID11915945.
"Activity/stability of human pepsin: implications for reflux attributed laryngeal disease". The Laryngoscope. 117 (6): 1036–9. June 2007. doi:10.1097/MLG.0b013e31804154c3. PMID17417109.
"Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease". The Laryngoscope. 114 (12): 2129–34. December 2004. doi:10.1097/01.mlg.0000149445.07146.03. PMID15564833.
"Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease". The Annals of Otology, Rhinology, and Laryngology. 115 (1): 47–58. January 2006. doi:10.1177/000348940611500108. PMID16466100.
"Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology". Journal of Gastrointestinal Surgery. 8 (7): 890–7, discussion 897–8. November 2004. doi:10.1016/j.gassur.2004.08.001. PMID15531244.
"Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study". The American Journal of Gastroenterology. 99 (6): 1000–10. June 2004. doi:10.1111/j.1572-0241.2004.30349.x. PMID15180717.
"Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment". Journal of Gastrointestinal Surgery. 10 (1): 54–62. January 2006. doi:10.1016/j.gassur.2005.09.005. PMID16368491.
"Receptor-mediated uptake of pepsin by laryngeal epithelial cells". The Annals of Otology, Rhinology, and Laryngology. 116 (12): 934–8. December 2007. doi:10.1177/000348940711601211. PMID18217514.
"Rationale for targeting pepsin in the treatment of reflux disease". The Annals of Otology, Rhinology, and Laryngology. 119 (8): 547–58. August 2010. doi:10.1177/000348941011900808. PMID20860281.
"Pepsin as a causal agent of inflammation during nonacidic reflux". Otolaryngology–Head and Neck Surgery. 141 (5): 559–63. November 2009. doi:10.1016/j.otohns.2009.08.022. PMID19861190.
"Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch". Archives of Otolaryngology–Head & Neck Surgery. 126 (3): 405–9. March 2000. doi:10.1001/archotol.126.3.405. PMID10722017.
"Pepsin as a marker of extraesophageal reflux". The Annals of Otology, Rhinology, and Laryngology. 119 (3): 203–8. March 2010. doi:10.1177/000348941011900310. PMID20392035.
"Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3". Nature Structural Biology. 7 (8): 653–7. August 2000. doi:10.1038/77950. PMID10932249.
"Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development". Cellular and Molecular Life Sciences. 59 (2): 288–306. February 2002. doi:10.1007/s00018-002-8423-9. PMID11915945.
"Activity/stability of human pepsin: implications for reflux attributed laryngeal disease". The Laryngoscope. 117 (6): 1036–9. June 2007. doi:10.1097/MLG.0b013e31804154c3. PMID17417109.
"Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease". The Laryngoscope. 114 (12): 2129–34. December 2004. doi:10.1097/01.mlg.0000149445.07146.03. PMID15564833.
"Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease". The Annals of Otology, Rhinology, and Laryngology. 115 (1): 47–58. January 2006. doi:10.1177/000348940611500108. PMID16466100.
"Role of the components of the gastroduodenal contents in experimental acid esophagitis". Surgery. 92 (2): 276–84. August 1982. PMID6808683.
"Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology". Journal of Gastrointestinal Surgery. 8 (7): 890–7, discussion 897–8. November 2004. doi:10.1016/j.gassur.2004.08.001. PMID15531244.
"Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study". The American Journal of Gastroenterology. 99 (6): 1000–10. June 2004. doi:10.1111/j.1572-0241.2004.30349.x. PMID15180717.
"Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment". Journal of Gastrointestinal Surgery. 10 (1): 54–62. January 2006. doi:10.1016/j.gassur.2005.09.005. PMID16368491.
"Receptor-mediated uptake of pepsin by laryngeal epithelial cells". The Annals of Otology, Rhinology, and Laryngology. 116 (12): 934–8. December 2007. doi:10.1177/000348940711601211. PMID18217514.
"Rationale for targeting pepsin in the treatment of reflux disease". The Annals of Otology, Rhinology, and Laryngology. 119 (8): 547–58. August 2010. doi:10.1177/000348941011900808. PMID20860281.
"Pepsin as a causal agent of inflammation during nonacidic reflux". Otolaryngology–Head and Neck Surgery. 141 (5): 559–63. November 2009. doi:10.1016/j.otohns.2009.08.022. PMID19861190.
"Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch". Archives of Otolaryngology–Head & Neck Surgery. 126 (3): 405–9. March 2000. doi:10.1001/archotol.126.3.405. PMID10722017.
"Pepsin as a marker of extraesophageal reflux". The Annals of Otology, Rhinology, and Laryngology. 119 (3): 203–8. March 2010. doi:10.1177/000348941011900310. PMID20392035.
"Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3". Nature Structural Biology. 7 (8): 653–7. August 2000. doi:10.1038/77950. PMID10932249.